Investigating Dupilumab's Effect in Asthma by Genotype
Investigating Dupilumab's Effect in Asthma by Genotype
Active, not recruiting · NCT03694158 · Registry updated 2026-02-23Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Investigating Dupilumab's Effect in Asthma by Genotype | Hypersensitivity, Immediate, Respiratory Hypersensitivity, asthma, bronchial disorder, immune system disorder, lung disorder, obstructive lung disease, respiratory system disorder | Active, not recruiting | Phase 4 | 2026-02-23 | NCT03694158 |
6 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Boston Children's Hospital | 238 |
| HealthBeacon Plc | 1 |
| Merck Sharp & Dohme LLC | 650 |
| National Institute of Allergy and Infectious Diseases (NIAID) | 402 |
| Regeneron Pharmaceuticals | 238 |
| Sanofi | 254 |
6 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Boston Children's Hospital | Boston | United States | 343 |
| Brigham and Women's Hospital | Boston | United States | 511 |
| Henry Ford Health System | Detroit | United States | 147 |
| MetroHealth System | Cleveland | United States | 4 |
| Montefiore Einstein Clinical Research Center | The Bronx | United States | 1 |
| University of Pennsylvania | Philadelphia | United States | 507 |